
Soni Medicare (SML) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
68.7M
Gross Profit
36.4M
53.06%
Operating Income
5.5M
7.96%
Net Income
3.5M
5.05%
Balance Sheet Metrics
Total Assets
221.7M
Total Liabilities
208.6M
Shareholders Equity
13.1M
Debt to Equity
15.94
Cash Flow Metrics
Revenue & Profitability Trend
Soni Medicare Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 298.4M | 272.5M | 275.3M | 226.0M | 157.9M |
Cost of Goods Sold | 84.9M | 81.4M | 84.4M | 73.4M | 27.1M |
Gross Profit | 213.5M | 191.2M | 190.9M | 152.6M | 130.8M |
Gross Margin % | 71.6% | 70.2% | 69.3% | 67.5% | 82.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 93.3M | 90.8M | 68.1M | 46.1M |
Other Operating Expenses | 139.9M | 39.0M | 43.3M | 35.7M | 35.5M |
Total Operating Expenses | 139.9M | 132.3M | 134.1M | 103.8M | 81.6M |
Operating Income | 7.6M | -8.3M | 642.8K | -1.5M | 5.5M |
Operating Margin % | 2.6% | -3.0% | 0.2% | -0.7% | 3.5% |
Non-Operating Items | |||||
Interest Income | - | 1.2M | 1.1M | 922.1K | 588.8K |
Interest Expense | 9.9M | 8.2M | 6.7M | 5.8M | 6.4M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -2.2M | -16.3M | -6.1M | -6.7M | -6.2M |
Income Tax | -353.0K | 543.4K | 624.1K | -677.2K | -471.7K |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -1.9M | -16.8M | -6.7M | -6.0M | -5.7M |
Net Margin % | -0.6% | -6.2% | -2.4% | -2.7% | -3.6% |
Key Metrics | |||||
EBITDA | 12.7M | -1.8M | 9.0M | 6.9M | 12.3M |
EPS (Basic) | - | ₹-3.94 | ₹-1.58 | ₹-1.42 | ₹-1.34 |
EPS (Diluted) | - | ₹-3.94 | ₹-1.58 | ₹-1.42 | ₹-1.34 |
Basic Shares Outstanding | - | 4264900 | 4264900 | 4264900 | 4264900 |
Diluted Shares Outstanding | - | 4264900 | 4264900 | 4264900 | 4264900 |
Income Statement Trend
Soni Medicare Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 20.1M | 13.0M | 8.7M | 6.0M | 9.2M |
Short-term Investments | 3.7M | 28.3K | 45.3K | 39.4K | 2.5K |
Accounts Receivable | 87.6M | 70.9M | 78.2M | 62.6M | 39.8M |
Inventory | 8.9M | 5.3M | 4.8M | 7.3M | 11.6M |
Other Current Assets | 4.8M | 21.5M | 20.9M | 21.8M | 16.7M |
Total Current Assets | 137.8M | 114.3M | 116.5M | 101.9M | 83.9M |
Non-Current Assets | |||||
Property, Plant & Equipment | 60.3M | 90.9M | 89.8M | 89.0M | 19.0M |
Goodwill | 2.9M | 3.1M | 3.2M | 3.3M | 3.4M |
Intangible Assets | - | 3.1M | 3.2M | 3.3M | 3.4B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | 6.2K |
Total Non-Current Assets | 83.9M | 82.4M | 84.4M | 87.0M | 86.1M |
Total Assets | 221.7M | 196.6M | 200.9M | 188.9M | 170.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 67.2M | 49.8M | 52.2M | 48.5M | 27.6M |
Short-term Debt | 11.1M | 6.6M | 37.6M | 34.1M | 66.4M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 2.3M | 2.5M | 2.0M | 2.1M | 1.5M |
Total Current Liabilities | 103.8M | 80.1M | 107.6M | 100.2M | 109.3M |
Non-Current Liabilities | |||||
Long-term Debt | 94.1M | 91.2M | 49.5M | 39.3M | 4.8M |
Deferred Tax Liabilities | 4.1M | 4.9M | 4.3M | 3.7M | 4.4M |
Other Non-Current Liabilities | -100.0K | 1 | -1 | - | 1.0K |
Total Non-Current Liabilities | 104.8M | 100.3M | 60.4M | 49.0M | 14.9M |
Total Liabilities | 208.6M | 180.5M | 167.9M | 149.2M | 124.3M |
Equity | |||||
Common Stock | 42.6M | 42.6M | 42.6M | 42.6M | 42.6M |
Retained Earnings | - | -27.9M | -11.1M | -4.3M | 1.7M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 13.1M | 16.2M | 33.0M | 39.7M | 45.8M |
Key Metrics | |||||
Total Debt | 105.2M | 97.8M | 87.2M | 73.4M | 71.2M |
Working Capital | 33.9M | 34.1M | 8.9M | 1.7M | -25.5M |
Balance Sheet Composition
Soni Medicare Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -2.2M | -16.3M | -6.1M | -6.7M | -6.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -16.8M | 11.1M | -7.7M | -14.9M | -14.9M |
Operating Cash Flow | -10.1M | -1.8M | -8.1M | -15.5M | -14.0M |
Investing Activities | |||||
Capital Expenditures | -6.6M | -2.7M | -3.9M | -8.5M | -3.8M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -6.3M | -2.9M | -3.7M | -8.2M | -3.5M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 7.4M | 10.6M | 10.2M | 34.5M | - |
Debt Repayment | 0 | 0 | 0 | 0 | -20.8M |
Financing Cash Flow | 7.4M | 10.6M | 10.2M | 34.5M | -20.8M |
Free Cash Flow | 8.8M | 1.2M | -1.9M | -32.4M | 28.9M |
Net Change in Cash | -9.0M | 5.9M | -1.6M | 10.7M | -38.2M |
Cash Flow Trend
Soni Medicare Key Financial Ratios
Valuation Ratios
Price to Book
11.20
Price to Sales
0.79
Profitability Ratios
Profit Margin
-0.60%
Operating Margin
7.28%
Return on Equity
-12.79%
Return on Assets
2.28%
Financial Health
Current Ratio
1.33
Debt to Equity
810.21
Beta
-0.40
Per Share Data
EPS (TTM)
₹-0.44
Book Value per Share
₹5.16
Revenue per Share
₹123.80
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
sml | 246.3M | - | 11.20 | -12.79% | -0.60% | 810.21 |
Max Healthcare | 1.3T | 114.44 | 13.01 | 12.10% | 15.31% | 32.09 |
Apollo Hospitals | 1.1T | 73.20 | 12.91 | 18.85% | 6.63% | 90.89 |
Indraprastha Medical | 46.6B | 26.86 | 7.26 | 29.97% | 11.87% | 5.49 |
Shalby | 22.2B | 1,219.53 | 2.04 | 0.19% | 0.57% | 9.69 |
Dr. Agarwal's Eye | 20.7B | 37.47 | 9.80 | 29.80% | 13.76% | 158.94 |
Financial data is updated regularly. All figures are in the company's reporting currency.